Nephrodite

Nephrodite is a medical device company developing "Holly," a first-of-its-kind, fully implantable artificial kidney designed to transform the treatment of End-Stage Renal Disease (ESRD). The device aims to provide continuous, 24/7 blood purification, mimicking the natural function of a biological kidney and eliminating the need for traditional, tethered dialysis. By providing a more physiological and mobile solution, Nephrodite seeks to improve patient longevity and quality of life while reducing the healthcare costs associated with chronic kidney care. The company is currently in the pre-clinical stage, focusing on refining the device's filtration efficiency and biocompatibility.